Fig. 1From: A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancerSample selection for the identification of prognostic genes in glioblastoma multiforme. PFS: progression-free survival (days); OS: overall survival (days); adjuvant treatment: chemotherapy and radiationBack to article page